# PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide

> **NCT00744224** · NA · COMPLETED · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 8 (estimated)

## Conditions studied

- Glucocorticoid-induced Glucometabolic Abnormalities
- Glucocorticoid-induced Beta-cell Dysfunction

## Interventions

- **DRUG:** Placebo
- **DRUG:** Prednisolone
- **DRUG:** Prednisolone and Exenatide

## Key facts

- **NCT ID:** NCT00744224
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2010-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00744224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00744224, "PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00744224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*